Stay updated on Periop Chemo & Pembrolizumab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Periop Chemo & Pembrolizumab in Gastric Cancer Clinical Trial page.

Latest updates to the Periop Chemo & Pembrolizumab in Gastric Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedConsolidated location information under a new Locations section including Missouri, New York, and Rhode Island. The prior separate location subsections and the HHS Vulnerability Disclosure link were removed.SummaryDifference0.4%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedRevision tag updated to v3.3.2, replacing the previous v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedPubMed publication note updated to say publications are automatically filled in from PubMed and may not be about the study. The revision label changed from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check49 days agoChange DetectedDeleted the notice about a lapse in government funding from the page footer. The disclaimer that information may not be up to date has been removed, leaving the study details unchanged.SummaryDifference0.4%

- Check63 days agoChange DetectedResults for the trial have been posted and a dedicated Results section with the outcomes and a PubMed reference is now visible on the study page.SummaryDifference0.4%

- Check92 days agoChange Detected- Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.SummaryDifference3%

Stay in the know with updates to Periop Chemo & Pembrolizumab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Periop Chemo & Pembrolizumab in Gastric Cancer Clinical Trial page.